POTENTIAL NEW GENETIC AND BIOCHEMICAL MARKERS OF CHRONIC KIDNEY FAILURE

Research output: Contribution to conferenceOtherpeer-review

Abstract

disease (CKD) is an important source of long-term morbidity and mortality. It has been estimated that CKD affects more than 20 million people in the United States. Given that most patients are asymptomatic until the disease has significantly progressed, they remain unaware of the condition. Thus, it is essential to have clinical practice guidelines (BIOMARKERS aimed at early detection, evaluation, diagnosis, and treatment of this condition.
Original languageEnglish
Pages111-123
Number of pages13
Publication statusPublished - 2017

Fingerprint

Dive into the research topics of 'POTENTIAL NEW GENETIC AND BIOCHEMICAL MARKERS OF CHRONIC KIDNEY FAILURE'. Together they form a unique fingerprint.

Cite this